Inovio Pharmaceuticals Inc (INO)

7.09
0.22 3.00
NASDAQ : Health Care
Prev Close 7.31
Open 7.17
Day Low/High 6.98 / 7.25
52 Wk Low/High 4.50 / 11.69
Volume 447.01K
Avg Volume 1.11M
Exchange NASDAQ
Shares Outstanding 74.06M
Market Cap 524.35M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Inovio's Co-Founder And Chair Of Its Scientific Advisory Board Selected As A Top 20 Translational Researcher

Inovio's Co-Founder And Chair Of Its Scientific Advisory Board Selected As A Top 20 Translational Researcher

Dr. David B. Weiner recognized for his innovative medical and scientific research, which has been the basis for over 100 patents

Inovio's Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses In Tumor Tissue And Peripheral Blood In Patients With HPV-Associated Head And Neck Cancer

Inovio's Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses In Tumor Tissue And Peripheral Blood In Patients With HPV-Associated Head And Neck Cancer

Four of five study subjects in treated group show progression free survival ranging from nine to 24 months to date in phase I/IIa clinical study

Wall Street Ends With Gains as T-Mobile, B/E Aerospace Hit Highs

Wall Street Ends With Gains as T-Mobile, B/E Aerospace Hit Highs

Stocks closed with gains on Monday as T-Mobile led the Nasdaq amid better-than-expected earnings, while B/E Aerospace soared following announcement of its acquisition by Rockwell Collins.

Stocks Pare Some Gains, but Still Up on Positive Earnings, M&A

Stocks Pare Some Gains, but Still Up on Positive Earnings, M&A

Stocks stay in the green Monday as M&A and earnings reports lead the market higher, while manufacturing orders rise.

RSI Alert: Inovio Pharmaceuticals (INO) Now Oversold

RSI Alert: Inovio Pharmaceuticals (INO) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

INO Crosses Below Key Moving Average Level

INO Crosses Below Key Moving Average Level

In trading on Friday, shares of Inovio Pharmaceuticals Inc. crossed below their 200 day moving average of $8.62, changing hands as low as $8.60 per share.

First Week of INO May 2017 Options Trading

First Week of INO May 2017 Options Trading

Investors in Inovio Pharmaceuticals Inc. saw new options begin trading this week, for the May 2017 expiration.

Inovio's Zika Vaccine Selected As 2016 Technology Breakthrough

Inovio's Zika Vaccine Selected As 2016 Technology Breakthrough

Popular Mechanics magazine calls Inovio's Zika prevention a completely new form of vaccination that may be the fastest vaccine ever to come to market

How to Cash in on the Fight Against the Zika Virus

How to Cash in on the Fight Against the Zika Virus

Where some see danger and upheaval, investors see opportunity. And the harrowing Zika virus is no different. Investors are jumping into stocks focused on detecting or wiping out the virus.

Inovio (INO) Stock Climbs, Launches Zika Vaccine Trial

Inovio (INO) Stock Climbs, Launches Zika Vaccine Trial

Inovio (INO) said on Monday that it initiated a clinical study of its preventive Zika vaccine in 160 subjects in Puerto Rico.

Inovio Launches Zika Vaccine Trial In Midst Of Puerto Rico Epidemic To Explore Early Signals Of Vaccine Efficacy

Inovio Launches Zika Vaccine Trial In Midst Of Puerto Rico Epidemic To Explore Early Signals Of Vaccine Efficacy

Inovio's second human Zika vaccine study, a placebo-controlled 160-subject trial, will test for safety, immune responses and initial evidence of efficacy

4 Stocks for Fighting Zika

4 Stocks for Fighting Zika

With a new Zika case now confirmed on Florida's East Coast, here's four stocks investors should consider as concerns about the virus reach an all-time high

Interesting INO Put And Call Options For October 21st

Interesting INO Put And Call Options For October 21st

Investors in Inovio Pharmaceuticals Inc. saw new options become available today, for the October 21st expiration.

Inovio Pharmaceuticals Expands Positive Phase I Ebola Vaccine Trial To Identify Most Optimal Immunization Regimen

Inovio Pharmaceuticals Expands Positive Phase I Ebola Vaccine Trial To Identify Most Optimal Immunization Regimen

Further enrollment to also build on safety database for Ebola and SynCon® immunotherapy technology, which has a favorable safety profile to date

Today's Weak On High Volume Stock: Inovio Pharmaceuticals (INO)

Today's Weak On High Volume Stock: Inovio Pharmaceuticals (INO)

Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a weak on high relative volume candidate

Inovio (INO) Stock Slumps After Mixed Q2 Results

Inovio (INO) Stock Slumps After Mixed Q2 Results

Inovio (INO) reported a bigger-than-expected loss for the 2016 second quarter before Monday's market open.

Inovio Pharmaceuticals (INO) Is Today's Dead Cat Bounce Stock

Inovio Pharmaceuticals (INO) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a "dead cat bounce" (down big yesterday but up big today) candidate